Scribe Therapeutics logo

Scribe Therapeutics

Alameda, CA

Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

scribetx.com

Company Details

Founded

2017

Employees

Between 50 - 200 employees

Raised

$120,000,000

Headquarters Location

Alameda, CA

Public

No

Acquired

No

CEO

Benjamin OakesBenjamin Oakes

Founders

Brett T Staahl
Brett T Staahl
Benjamin Oakes
Benjamin Oakes
Jennifer A. Doudna
Jennifer A. Doudna
David Savage
David Savage

Company Collections

These are collections Scribe Therapeutics is a part of. Click on the collection name to view similar companies.

Scribe Therapeutics' Investors

Scribe Therapeutics' Industries

Scribe Therapeutics' Tech Stack

Scribe Therapeutics Headquarters Location

1150 Marina Village Pkwy, Alameda, CA 94501

Total Amount Raised: $120,000,000

Scribe Therapeutics' Investors

Scribe Therapeutics Funding Rounds

  • Series B

    $100,000,000

    Series B Investors

    Avoro Capital Advisors
    Avoro Ventures
    Menlo Ventures
    RA Capital Management
    OrbiMed Advisors
    Perceptive Advisors
    Andreessen Horowitz
    T. Rowe Price
    Wellington Management

  • Series A

    $20,000,000

    Series A Investors

    Andreessen Horowitz
Funding info provided by Diffbot.

Scribe Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Scribe Therapeutics.

Recent reviews